Spago Nanomedical Revenue vs. Shares Outstanding
| SPAGO Stock | SEK 0.19 0.01 5.00% |
For Spago Nanomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Spago Nanomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Spago Nanomedical AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Spago Nanomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Spago Nanomedical AB over time as well as its relative position and ranking within its peers.
Spago |
Spago Nanomedical Shares Outstanding vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Spago Nanomedical's current stock value. Our valuation model uses many indicators to compare Spago Nanomedical value to that of its competitors to determine the firm's financial worth. Spago Nanomedical AB is currently regarded number one company in revenue category among its peers. It is rated second in shares outstanding category among its peers creating about 137.79 of Shares Outstanding per Revenue. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spago Nanomedical's earnings, one of the primary drivers of an investment's value.Spago Revenue vs. Competition
Spago Nanomedical AB is currently regarded number one company in revenue category among its peers. Market size based on revenue of Biotechnology industry is at this time estimated at about 24.23 Million. Spago Nanomedical holds roughly 660,000 in revenue claiming about 2.72% of stocks in Biotechnology industry.
Spago Shares Outstanding vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Spago Nanomedical |
| = | 660 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Spago Nanomedical |
| = | 90.94 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Spago Shares Outstanding Comparison
Spago Nanomedical is currently under evaluation in shares outstanding category among its peers.
Spago Nanomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Spago Nanomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Spago Nanomedical will eventually generate negative long term returns. The profitability progress is the general direction of Spago Nanomedical's change in net profit over the period of time. It can combine multiple indicators of Spago Nanomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Spago Nanomedical AB develops nanomaterials for cancer diagnostics and treatment. Spago Nanomedical AB was founded in 2007 and is based in Lund, Sweden. Spago Nanomedical is traded on Stockholm Stock Exchange in Sweden.
Spago Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Spago Nanomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Spago Nanomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Spago Nanomedical's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Spago Nanomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Use Investing Themes to Complement your Spago Nanomedical position
In addition to having Spago Nanomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Risk ETFs Thematic Idea Now
Target Risk ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Spago Stock Analysis
When running Spago Nanomedical's price analysis, check to measure Spago Nanomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spago Nanomedical is operating at the current time. Most of Spago Nanomedical's value examination focuses on studying past and present price action to predict the probability of Spago Nanomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spago Nanomedical's price. Additionally, you may evaluate how the addition of Spago Nanomedical to your portfolios can decrease your overall portfolio volatility.